Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Analysis of CYP27B1 in multiple sclerosis.
Erythropoietin Levels in Patients with Multiple SclerosisComplicated with Anemia.
Alpha beta-crystallin expression and presentation following infection with murine gammaherpesvirus 68.
Mediation of Protection and Recovery From Experimental Autoimmune Encephalomyelitis by Macrophages Expressing the Human Voltage-Gated Sodium Channel NaV1.5.
Specialized housing and transportation needs of adults with multiple sclerosis.
Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.
Effect of spasticity on kinematics of gait and muscular activation in people with Multiple Sclerosis.
Translating CESD-20 and PHQ-9 Scores to PROMIS Depression.
Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis.
Potential role of immunoglobulin replacement therapy on MRI measures in multiple sclerosis: a systematic review.
Molecular approach to targeted therapy for multiple sclerosis.
Selective accumulation of pro-inflammatory T cells in the intestine contributes to the resistance to autoimmune demyelinating disease.
Psychometric properties of quality of life and health-related quality of life assessments in people with multiple sclerosis.
Lipoprotein-associated lysolipids are differentially involved in high-density lipoprotein- and its oxidized form-induced neurite remodeling in PC12 cells.
Altered functional connectivity and performance variability in relapsing-remitting multiple sclerosis.
Coenzyme Q10 supplementation and multiple sclerosis.
Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G.
Autoantibodies to Glutamate Receptor Antigens in Multiple Sclerosis and Rasmussen's Encephalitis.
Symptomatic treatment and management of multiple sclerosis.
Dietary intake of nutrients and its correlation with fatigue in multiple sclerosis patients.
Phase White Matter Signal Abnormalities in Patients with Clinically Isolated Syndrome and Other Neurologic Disorders.
Suppression of miR-155 Expression in IFN-γ-Treated Astrocytes and Microglia by DJ-1: A Possible Mechanism for Maintaining SOCS1 Expression.
Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.
A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells.
Pages
« first
‹ previous
…
569
570
571
572
573
574
575
576
577
…
next ›
last »